SINO BIOPHARMACEUTICAL
Sino Biopharmaceutical engages in pharmaceutical products which covers an array of R&D platforms, a line-up of intelligent production and a strong sales system. The Group's products have gained a competitive foothold in various therapeutic categories with promising potentials, comprising a variety of biopharmaceutical and chemical medicines for treating tumours, liver diseases, cardio-cerebral diseases, analgesia, respiratory system diseases and orthopedicdiseases.
SINO BIOPHARMACEUTICAL
Industry:
Biotechnology Health Care Health Diagnostics Hospital Medical Pharmaceutical
Founded:
1997-02-02
Status:
Active
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible Nginx Euro Google Apps For Business Pound Sterling Japanese Yen Java EE Network Solutions DNS Unsplash
Similar Organizations
Celator Pharmaceuticals
Celator Pharmaceuticals is a biopharmaceutical company developing therapies to treat cancer, using the drug ratio technology platform.
Fatigue Science Institute
Fatigue Science is a research, development and sales of medical technology and medical supplies for various diseases, and treatment.
Kanzawa Medical Research Foundation
Kanzawa Medical Research Foundation promotes the development of healthcare and medical science by encouraging studies.
Samjin Pharmaceutical
Samjin Pharmaceutical is a company that pioneeres a healthy life for human beings with a creative mind and advances for a prosperous future.
Current Employees Featured
Founder
Stock Details
Acquisitions List
| Date | Company | Article | Price |
|---|---|---|---|
| 2021-03-23 | Softhale | Softhale acquired by Sino Biopharmaceutical | 110 M USD |
Investments List
| Date | Company | Article | Money raised |
|---|---|---|---|
| 2022-06-02 | Generon (Shanghai) Corporation | Sino Biopharmaceutical investment in Venture Round - Generon (Shanghai) Corporation | 70 M USD |
| 2021-12-12 | Medlinker | Sino Biopharmaceutical investment in Series E - Medlinker | 514 M USD |
| 2021-11-18 | Treadwell Therapeutics | Sino Biopharmaceutical investment in Series B - Treadwell Therapeutics | 91 M USD |
| 2021-08-11 | XtalPi | Sino Biopharmaceutical investment in Series D - XtalPi | 400 M USD |
| 2020-12-06 | Sinovac Life Sciences | Sino Biopharmaceutical investment in Corporate Round - Sinovac Life Sciences | 500 M USD |
| 2019-11-04 | Akeso Biopharma | Sino Biopharmaceutical investment in Series D - Akeso Biopharma | 150 M USD |
| 2015-08-05 | LifeBond | Sino Biopharmaceutical investment in Series D - LifeBond | 27 M USD |
More informations about "Sino Biopharmaceutical"
Sino Biopharmaceutical Limited - Wikipedia
Sino Biopharmaceutical Limited (SEHK: 1177|Hang Seng Index component) (simplified Chinese: ไธญๅฝ็็ฉๅถ่ฏๆ้ๅ ฌๅธ; traditional Chinese: ไธญๅ็็ฉ่ฃฝ่ฅๆ้ๅ ฌๅธ; pinyin: zhลng guó shฤng wù zhì yào yวu xiàn gลng sฤซ), shortly Sino Biopharm, is a civilian-run enterprise principally engaged in the medicine products business in Mainland China. Being a member of Charoen Pokphand Group and headquartered in Hong Kong and Beijing, Sino โฆSee details»
Sino Biopharm
Since incorporation, Sino Biopharmaceutical Limited continues to break its own record in terms of revenue and net profit, and was ranked one of the โAsiaโs Fab 50 Companiesโ by Forbes Asia โฆSee details»
Corporate Governance - Sino Biopharm
About Sino Biopharm Board of Directors Senior Management R&D R&D Team Products Product List Sustainability ESG Governance ESG Management Practices ESG Reports Investors โฆSee details»
Sino Biopharmaceutical, One of the Largest Chinese ... - Morningstar
May 9, 2024 Sino Biopharm has a good financial position. As of December 2023, it has CNY 9.5 billion in cash on hand and CNY 12.2 billion in debt. Total debt outstanding is 19.2% of its total โฆSee details»
Sino Biopharmaceutical - Crunchbase
Sino Biopharmaceutical engages in pharmaceutical products which covers an array of R&D platforms, a line-up of intelligent production and a strong sales system. The Group's products have gained a competitive foothold in various โฆSee details»
SINO BIOPHARM (1177.HK) company profile and facts - Yahoo โฆ
See the company profile for SINO BIOPHARM (1177.HK), including business summary, industry/sector information, number of employees, corporate governance, key executives and โฆSee details»
SINO BIOPHARM (1177.HK) Company Profile & Facts - Yahoo โฆ
See the company profile for SINO BIOPHARM (1177.HK) including business summary, industry/sector information, number of employees, business summary, corporate governance, โฆSee details»
Sino Biopharm shows stable growth in 2023 - Chinadaily.com.cn
Nov 24, 2024 Sino Biopharmaceutical Limited. [Photo/Sino Biopharm website] Sino Biopharmaceutical Limited, or Sino Biopharm, a leading innovative research and development โฆSee details»
Presentation - Sino Biopharm
© 2023 Sino Biopharmaceutical Co., Ltd. All rights reserved. Friendly link invoX Pharma Limited CTTQ Pharmaceutical Tide Pharmaceutical CP Group CTTQ Pharmaceutical ...See details»
Sino Biopharm and Boehringer Ingelheim enter into โฆ
Apr 9, 2024 Sino Biopharmaceutical Limited, or Sino Biopharm, a China-based Hang Seng Index company, and Boehringer Ingelheim, a global biopharmaceutical company, announced on Monday that they had entered โฆSee details»
1177.HK - | Stock Price & Latest News | Reuters
Jun 5, 2024 Sino Biopharmaceutical Ltd 1177.HK. Official Data Partner. Latest Trade. trading lower 3.25 HKD. Change-0.01 % Change-0.31% Negative As of Nov 30, 2024. Values delayed โฆSee details»
Sino Biopharm profit surges 427.2% year-on-year
4 days ago Sino Biopharmaceutical Limited, or Sino Biopharm, a leading innovative research and development-driven pharmaceutical conglomerate in China, announced in its annual โฆSee details»
Sino Biopharmaceutical Ltd | Reuters
Jan 24, 2022 Sino Biopharmaceutical to divest 67% stake in unit CP Qingdao for $253 mln. February 7, 2024. China's CanSino Biologics reported a 69.5% drop in revenue for the first six โฆSee details»
News - Sino Biopharm
Aug 25, 2022 On the morning of August 24, Sino Biopharm (HK.01177) held its 2022 interim results conference and the first Investor Day in Beijing. The company's Chairwoman of the โฆSee details»
Sinopharm: Chinese Covid vaccine gets WHO emergency approval โฆ
May 7, 2021 The World Health Organization (WHO) has granted emergency approval for a Covid vaccine made by Chinese state-owned company Sinopharm. It is the first vaccine โฆSee details»
How the Sinopharm Covid-19 Vaccine Works - The New York Times
Dec 30, 2020 On May 7, the World Health Organization announced a similar efficacy estimate of 78.1 percent. A Vaccine Made From Coronaviruses BBIBP-CorV works by teaching the โฆSee details»
Sino Biopharmaceutical Gains Approval for Cancer Treatment
4 days ago Sino Biopharmaceutical has received approval from Chinaโs National Medical Products Administration for its Benmelstobart Injection, in combination with Anlotinib โฆSee details»
Information Disclosure - Sino Biopharm
About Sino Biopharm Board of Directors Senior Management R&D R&D Team Products Product List Sustainability ESG Governance ESG Management Practices ESG Reports Investors โฆSee details»